Clinical trial
Molecular Monitoring of cfDNA by ddPCR in Non-small Cell Lung Cancer Treated by Immunotherapy.
NCT04720339 is registered in ClinicalTrials.gov with University Hospital, Strasbourg, France as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Molecular Monitoring of cfDNA by ddPCR in Non-small Cell Lung Cancer Treated by Immunotherapy.
- Lead sponsor
- University Hospital, Strasbourg, France
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- May 27, 2021
- Completion date
- October 27, 2027
- Enrollment
- 250 (estimated)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
immunotherapy, nsclc, quantification of cell-free dna